Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Diabetes Treatment And Monitoring Devices Market | Acumen Research and Consulting

Diabetes Treatment and Monitoring Devices Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

Published : Jul 2024

Report ID: ARC262

Pages : 250

Format : Diabetes Treatment and Monitoring Devices Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

Summary Table of Content Customization Download Sample Infographics

CHAPTER 1. Industry Overview of Diabetes Treatment and Monitoring Devices Market

1.1. Definition and Scope

1.1.1. Definition of Diabetes Treatment and Monitoring Devices

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Diabetes Treatment and Monitoring Devices Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Diabetes Treatment and Monitoring Devices Market By Product Type

1.2.3. Diabetes Treatment and Monitoring Devices Market By Distribution Channel

1.2.4. Diabetes Treatment and Monitoring Devices Market By End Use

1.2.5. Diabetes Treatment and Monitoring Devices Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.1.3. Driver 3

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.2.3. Restraint 3

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.3.3. Opportunity 3

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Diabetes Treatment and Monitoring Devices Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Diabetes Treatment and Monitoring Devices Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Diabetes Treatment and Monitoring Devices Market By Product Type

5.1. Introduction

5.2. Diabetes Treatment and Monitoring Devices Revenue By Product Type

5.2.1. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast, By Product Type, 2020-2032

5.2.2. Treatment Devices

5.2.2.1. Treatment Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2. Insulin Delivery Devices

5.2.2.2.1. Insulin Delivery Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.2. Insulin Pens

5.2.2.2.2.1. Insulin Pens Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.3. Insulin Pumps

5.2.2.2.3.1. Insulin Pumps Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.2.4. Insulin Syringes

5.2.2.2.4.1. Insulin Syringes Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.2.3. Artificial Pancreas Devices Systems

5.2.2.3.1. Artificial Pancreas Devices Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Monitoring Devices

5.2.3.1. Monitoring Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.2. Continuous Glucose Monitoring (CGM) Systems

5.2.3.2.1. Continuous Glucose Monitoring (CGM) Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3. Self-Monitoring of Blood Glucose (SMBG) Systems

5.2.3.3.1. Self-Monitoring of Blood Glucose (SMBG) Systems Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.2. Blood Glucose Meters

5.2.3.3.2.1. Blood Glucose Meters Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.3. Testing Strips

5.2.3.3.3.1. Testing Strips Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3.3.4. Lancets

5.2.3.3.4.1. Lancets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Diabetes Treatment and Monitoring Devices Market By Distribution Channel

6.1. Introduction

6.2. Diabetes Treatment and Monitoring Devices Revenue By Distribution Channel

6.2.1. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032

6.2.2. Hospital Pharmacies

6.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Retail Pharmacies

6.2.3.1. Retail Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.4. Online Pharmacies

6.2.4.1. Online Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.5. Diabetes Clinics/Centers

6.2.5.1. Diabetes Clinics/Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Diabetes Treatment and Monitoring Devices Market By End Use

7.1. Introduction

7.2. Diabetes Treatment and Monitoring Devices Revenue By End Use

7.2.1. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast, By End Use, 2020-2032

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Clinics

7.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Home Healthcare

7.2.4.1. Home Healthcare Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Ambulatory Surgical Centers

7.2.5.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Diabetes Treatment and Monitoring Devices Market By Country 

8.1. North America Diabetes Treatment and Monitoring Devices Market Overview

8.2. U.S.

8.2.1. U.S. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

8.2.2. U.S. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.2.3. U.S. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

8.3. Canada

8.3.1. Canada Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

8.3.2. Canada Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

8.3.3. Canada Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Diabetes Treatment and Monitoring Devices Market By Country

9.1. Europe Diabetes Treatment and Monitoring Devices Market Overview

9.2. U.K.

9.2.1. U.K. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.2.2. U.K. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.2.3. U.K. Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

9.3. Germany

9.3.1. Germany Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.3.2. Germany Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.3.3. Germany Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

9.4. France

9.4.1. France Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.4.2. France Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.4.3. France Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

9.5. Spain

9.5.1. Spain Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.5.2. Spain Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.5.3. Spain Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

9.6.2. Rest of Europe Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.6.3. Rest of Europe Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia-Pacific Diabetes Treatment and Monitoring Devices Market By Country

10.1. Asia-Pacific Diabetes Treatment and Monitoring Devices Market Overview

10.2. China

10.2.1. China Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.2.2. China Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.2.3. China Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.3. Japan

10.3.1. Japan Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.3.2. Japan Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.3.3. Japan Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.4. India

10.4.1. India Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.4.2. India Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.4.3. India Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.5. Australia

10.5.1. Australia Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.5.2. Australia Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.5.3. Australia Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.6. South Korea

10.6.1. South Korea Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.6.2. South Korea Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.6.3. South Korea Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

10.7.2. Rest of Asia-Pacific Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.7.3. Rest of Asia-Pacific Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

10.8. Asia-Pacific PEST Analysis

CHAPTER 11. Latin America Diabetes Treatment and Monitoring Devices Market By Country

11.1. Latin America Diabetes Treatment and Monitoring Devices Market Overview

11.2. Brazil

11.2.1. Brazil Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.2.2. Brazil Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.2.3. Brazil Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

11.3. Mexico

11.3.1. Mexico Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.3.2. Mexico Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.3.3. Mexico Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

11.4.2. Rest of Latin America Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.4.3. Rest of Latin America Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Diabetes Treatment and Monitoring Devices Market By Country 

12.1. Middle East & Africa Diabetes Treatment and Monitoring Devices Market Overview

12.2. GCC

12.2.1. GCC Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.2.2. GCC Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.2.3. GCC Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

12.3. South Africa

12.3.1. South Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.3.2. South Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.3.3. South Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Product Type, 2020-2032

12.4.2. Rest of Middle East & Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.4.3. Rest of Middle East & Africa Diabetes Treatment and Monitoring Devices Revenue (USD Billion) and Forecast By End Use, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Diabetes Treatment and Monitoring Devices Market

13.1. Diabetes Treatment and Monitoring Devices Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Type Launches and Product Type Enhancements

13.2.3. Mergers And Acquisition In Global Diabetes Treatment and Monitoring Devices Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Abbott Laboratories

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Billion), 2023

14.1.3.2. Abbott Laboratories, 2023 Diabetes Treatment and Monitoring Devices Business Regional Distribution

14.1.4. Product Type /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Sanofi

14.3. B. Braun Melsungen AG

14.4. Bayer HealthCare AG

14.5. Becton

14.6. Johnson & Johnson

14.7. Dickinson and Company

14.8. Novo Nordisk

14.9. Medtronic

14.10. Roche

14.11. DexCom

14.12. AstraZeneca plc

14.13. Insulet

Frequently Asked Questions

How big is the diabetes treatment and monitoring devices market?

The diabetes treatment and monitoring devices market size was valued at USD 31.7 Billion in 2023.

What is the CAGR of the global diabetes treatment and monitoring devices market from 2024 to 2032?

The CAGR of diabetes treatment and monitoring devices is 8.4% during the analysis period of 2024 to 2032.

Which are the key players in the diabetes treatment and monitoring devices market?

The key players operating in the global market are including Abbott Laboratories, Sanofi , B. Braun Melsungen AG, Bayer HealthCare AG, Becton, Johnson & Johnson, Dickinson and Company, Novo Nordisk, Medtronic, Roche, DexCom, AstraZeneca plc, and Insulet

Which region dominated the global diabetes treatment and monitoring devices market share?

North America held the dominating position in diabetes treatment and monitoring devices industry during the analysis period of 2024 to 2032.

Which region registered fastest CAGR from 2024 to 2032?

Asia-Pacific region exhibited fastest growing CAGR for market of diabetes treatment and monitoring devices during the analysis period of 2024 to 2032.

What are the current trends and dynamics in the global diabetes treatment and monitoring devices industry?

The current trends and dynamics in the diabetes treatment and monitoring devices industry include increasing prevalence of diabetes worldwide, technological advancements in glucose monitoring devices, and rising awareness and healthcare expenditure.

Which product type held the maximum share in 2023?

The treatment devices product type held the maximum share of the diabetes treatment and monitoring devices industry.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date